Our findings suggest that DHM could alleviate pulmonary fibrosis by suppressing GLUT1 in mice and might also lead to a breakthrough in the treatment of IPF by regulating the glucose metabolism in fibroblasts. The gene discussed is SLC2A1; the disease is idiopathic pulmonary fibrosis.